statistiche ricercatore

Continente	#
NA - Nord America	494
EU - Europa	347
AS - Asia	272
SA - Sud America	48
AF - Africa	22
Continente sconosciuto - Info sul continente non disponibili	13
Totale	1.196

Nazione	#
US - Stati Uniti d'America	468
IT - Italia	127
SG - Singapore	78
CN - Cina	64
DE - Germania	46
RU - Federazione Russa	46
HK - Hong Kong	42
VN - Vietnam	42
BR - Brasile	37
IE - Irlanda	35
FI - Finlandia	24
FR - Francia	15
GB - Regno Unito	15
CA - Canada	13
IN - India	11
ZA - Sudafrica	10
NL - Olanda	9
MX - Messico	6
PL - Polonia	6
SE - Svezia	6
BD - Bangladesh	5
IL - Israele	5
AR - Argentina	4
JP - Giappone	4
UA - Ucraina	4
BE - Belgio	3
MA - Marocco	3
PK - Pakistan	3
VE - Venezuela	3
AT - Austria	2
CZ - Repubblica Ceca	2
EE - Estonia	2
ID - Indonesia	2
IQ - Iraq	2
KE - Kenya	2
LK - Sri Lanka	2
LT - Lituania	2
MU - Mauritius	2
PH - Filippine	2
TH - Thailandia	2
TN - Tunisia	2
A2 - ???statistics.table.value.countryCode.A2???	1
BA - Bosnia-Erzegovina	1
BH - Bahrain	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
EC - Ecuador	1
ES - Italia	1
GE - Georgia	1
GP - Guadalupe	1
GT - Guatemala	1
HN - Honduras	1
IR - Iran	1
JM - Giamaica	1
KG - Kirghizistan	1
KW - Kuwait	1
MZ - Mozambico	1
NP - Nepal	1
PS - Palestinian Territory	1
PY - Paraguay	1
RO - Romania	1
SC - Seychelles	1
SN - Senegal	1
SV - El Salvador	1
TR - Turchia	1
TT - Trinidad e Tobago	1
Totale	1.184

Nome	#
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy	163
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy	157
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy	156
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count	150
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020	124
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy	120
Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified?	92
Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area	81
Corrigendum to "Seroprevalence of SARS-CoV-2 in 1922 blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area" [Clin Microbiol Infect 27 (6) (2021 Jun) 914.e1-914.e4]	78
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection	75
Totale	1.196

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	31	0	0	0	0	2	1	3	2	1	4	2	16
2022/2023	124	6	8	2	9	6	10	0	2	42	0	37	2
2023/2024	78	10	8	3	3	7	14	4	3	0	5	12	9
2024/2025	282	4	23	4	36	5	17	21	9	58	24	24	57
2025/2026	488	36	34	65	58	47	18	88	31	49	29	17	16
2026/2027	148	2	25	38	63	20	0	0	0	0	0	0	0
Totale													1.196